Skip to main content

Gilead Sciences CDR [Cad Hedged](GILD-T)
TSX

Today's Change
Real-Time Last Update

Gilead Sciences CDR [Cad Hedged]

333 Lakeside Drive
Foster City CA 94404 USA
P: 650-574-3000
https://www.gilead.com

Sectors & Indices

Sector
Industry
Employees

Profile

Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).

Key Executives

NameTitle
Andrew D. DickinsonCFO
Daniel P. O'DayCEO/Chairman of the Board/Director
Dietmar BergerChief Medical Officer
Johanna MercierOther Executive Officer
Erin BurkhartChief Accounting Officer/Senior VP, Divisional
Keeley M. Cain WettanExecutive VP, Divisional/General Counsel

More from The Globe

Analysts’ forecast returns, recommendations and yields for all stocks in the S&P/TSX SmallCap Index
The S&P TSX composite index screen at the TMX Market Centre in Toronto is photographed on Friday, November 11, 2022.
Small caps to watch: Aecon, Maple Leaf Foods, Tecsys and more
Packages of Maple Leaf Foods chicken breasts are shown on a shelf at a grocery store in Oakville, Ont., Friday, Jan.6, 2023.
Thursday’s analyst upgrades and downgrades
A pumpjack operates at the Vermilion Energy site in Trigueres, France, June 14, 2024.
Wednesday’s analyst upgrades and downgrades
A Pet Valu store is pictured in Ottawa, Tuesday, Sept. 13, 2022.
number cruncher
Seven Canadian oil producers set to benefit from rising prices
For Number Cruncher column in Globe Investor/ROB only.
Bullish on Mullen Group Ltd.
Monica Rizk
Top non-resource stocks on the TSX with strong insider signals
Ted Dixon
Berkshire Hathaway shares have largest slide since Buffett’s resignation
FILE PHOTO: A screen displays the trading information for Berkshire Hathaway inc. as traders work on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., October 22, 2025. REUTERS/Brendan McDermid/File Photo

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Financial data provided by Zacks Investment Research.